|Last Price||Today's Change||52-Week Range||Trading Volume|
|1.29||0.00 (0.00%)||1.26 - 8.41||4.5 thousand (Below Avg)|
Market data as of 12:00AM 12/24/14. Quotes are delayed by at least 15 min.
Exelixis’ Collaborator Genentech Files New Drug Application for the Combination of Cobimetinib and Vemurafenib for the Treatment of Patients With BRAF V600 Mutation-Positive Advanced Melanoma
12/15/2014 1:00 AM ET